Literature DB >> 7035634

Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus.

H F Champsaur, G F Bottazzo, J Bertrams, R Assan, C Bach.   

Abstract

A 16-month-old girl presented with an episode of fever and acute thrombocytopenic purpura caused by a Coxsackie B5 virus. On days 13 to 23, laboratory evidence of diabetes mellitus was present, followed by a 2 1/2-month remission, then by definitive insulin-dependent diabetes. The involvement of virologic, immunologic, and genetic factors in the pathophysiology was substantiated by the following data: (1) Virus-induced glucose intolerance was produced in selected mouse strains. (2) Islet-cell antibodies were found one week before onset of diabetes; however, circulating lymphocytes of the child at that time suppressed insulin release from islets in vitro. (3) Immunogenetic analysis of the child revealed the presence of high-risk genetic markers. It is suggested that the convergence of an insulotropic variant virus, genetic predisposition, and perhaps some uncontrolled adjuvant factors, e.g. steroid therapy and DPT vaccination, may have determined insular damage and anti-islet autoimmune reactions, leading to insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035634     DOI: 10.1016/s0022-3476(82)80228-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Two distinct HLA-DR3 haplotypes are associated with age related heterogeneity in type 1 (insulin-dependent) diabetes.

Authors:  I Deschamps; A Marcelli-Barge; J C Poirier; O Cohen-Haguenauer; H Abderrahim; D Cohen; H Lestradet; J Hors
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

2.  Multi-system coxsackievirus B-6 infection with findings suggestive of diabetes mellitus.

Authors:  G Nigro; M E Pacella; E Patanè; M Midulla
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

3.  Induction of the chemokine interferon-gamma-inducible protein-10 in human pancreatic islets during enterovirus infection.

Authors:  A-K Berg; O Korsgren; G Frisk
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

4.  Serum antibodies against Coxsackie B1-6 viruses in type 1 diabetics.

Authors:  A M Alberti; C Amato; A Candela; F Costantino; M E Grandolfo; F Lombardi; F Novello; M Orsini; R Santoro
Journal:  Acta Diabetol Lat       Date:  1985 Jan-Mar

5.  Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination.

Authors:  K Helmke; A Otten; W R Willems; R Brockhaus; G Mueller-Eckhardt; T Stief; J Bertrams; H Wolf; K Federlin
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

6.  Diabetogenic potential of coxsackie B viruses in nature.

Authors:  G W Jordan; V Bolton; N J Schmidt
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

7.  Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes.

Authors:  T Mertens; D Grüneklee; H J Eggers
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

Review 8.  [Pathogenesis and immunotherapy of insulin-dependent (type I) diabetes mellitus].

Authors:  J Bertrams
Journal:  Klin Wochenschr       Date:  1983-03-15

9.  Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein-Barr virus that developed in the course of chemotherapy of multiple myeloma.

Authors:  Atsushi Fujiya; Hiroshi Ochiai; Toshihiro Mizukoshi; Atsushi Kiyota; Taiga Shibata; Atsushi Suzuki; Norimi Ohashi; Hiroshi Sobajima
Journal:  J Diabetes Investig       Date:  2010-12-03       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.